ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HENRY SANDERS M.D.

Internal Medicine

487

$6,806

313
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$14
Average prescription price

Avg: $51

CHI-KUANG LAI MD

Internal Medicine

662

$14.2K

395
269 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 22%

$21
Average prescription price

Avg: $51

ALEX MANDEL M.D.

Internal Medicine

5,600

$136K

180
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$24
Average prescription price

Avg: $51

STUART DEMIRS M.D.

Internal Medicine

3,261

$88.4K

174
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 22%

$27
Average prescription price

Avg: $51

JOHN HAND MD

Internal Medicine

653

$18.9K

177
152 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$29
Average prescription price

Avg: $51

USHA KUMAR M.D

Internal Medicine

2,172

$64.1K

126
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$30
Average prescription price

Avg: $51

FRANK BAFFONI MD

Internal Medicine

5,086

$156K

257
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $51

KATHRYN SKELLY MD

Internal Medicine

721

$22.7K

56
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $51

FRANK SAVORETTI MD

Internal Medicine

7,794

$248K

490
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $51

CHRISTINE DUFFY MD

Internal Medicine

1,155

$37.2K

171
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $51

SHEENAGH BODKIN MD

Internal Medicine

980

$33K

84
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $51

JAMES SULLIVAN MD

Internal Medicine

5,830

$201K

347
282 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $51

MARCEL BAVOUX D.O.

Internal Medicine

3,192

$111K

477
246 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $51

AMIR ALIZADEH,MD INC. MD

Internal Medicine

14,991

$534K

592
534 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

CAROLINA FONSECA VALENCIA M.D.

Internal Medicine

1,128

$40.4K

61
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

FRANK AMALFITANO M.D.

Internal Medicine

7,011

$256K

249
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

LETITIA HORRIGAN D.O.

Internal Medicine

2,037

$75.1K

234
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

ANGELO DICENSO M.D.

Internal Medicine

13,999

$516K

626
579 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

FRED FERRI MD

Internal Medicine

14,192

$525K

568
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

JAVID CALCATTI MD

Internal Medicine

6,034

$224K

264
219 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

MALCOLM MACDONALD M.D.

Internal Medicine

3,326

$123K

173
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

JOB SANDOVAL MD

Internal Medicine

17,471

$653K

686
626 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

JEANNE OLIVA MD

Internal Medicine

5,022

$188K

304
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

KIMBERLY BABB MD

Internal Medicine

1,914

$71.6K

131
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

JAMES YESS

Internal Medicine

5,078

$190K

223
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank